Christopher Jackson, MD, is a radiation oncologist at Memorial Sloan Kettering Cancer Center (MSK) specializing in the treatment of cancer in both pediatric and adult populations. He completed his medical school training and residency at MSK, where he conducted clinical research focused on pediatric and adult brain tumors and spine metastases. Dr. Jackson sees patients at Memorial Hospital and the New York Proton Center in New York City. His clinical practice covers a broad range of diagnoses, including sarcoma, brain and spinal tumors, neuroblastoma, lymphoma, leukemia, and Wilms' tumor in children and adolescents, as well as brain tumors, brain metastases, spine tumors, and spinal metastases in adults. He is experienced in advanced radiation techniques, including proton therapy, intensity-modulated radiation therapy, intra-operative radiation therapy, stereotactic body radiation therapy, and stereotactic radiosurgery.
Why they are a top doctor
Research papers · PubMed
694
Published, peer-reviewed work, the clearest public measure of expertise in a specialty.
Known for
Proton therapy and intensity-modulated radiation therapy (IMRT)
The distinction that sets them apart from other radiation oncologists.
Specializes in
Image-guided radiation therapy (IGRT) and intraoperative radiation therapy (IORT)
A narrow focus means they see far more of these cases than a general oncologist.
Background
Education
Medical school: Bachelor of Science, Bioengineering, Stanford University · MD, Columbia University Vagelos College of Physicians and Surgeons · Master of Science, Biomedical Sciences, Columbia University Vagelos College of Physicians and Surgeons
Residency: Radiation Oncology, Memorial Sloan Kettering Cancer Center
Awards
Young Investigator Award, Particle Therapy Co-operative Group North America (2024)
Young Investigator Abstract Award, Children's Oncology Group (2024)
Annual Meeting Abstract Award, American Society for Radiation Oncology (2024)
Conquer Cancer Merit Award, American Society of Clinical Oncology (2024)